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The first steps in infection of influenza A virus is contact with the host cell membrane, with which it 
later fuses. The composition of the target bilayer exerts a complex influence on both fusion efficiency 
and time. Here, an in vitro, single-particle approach is used to study this effect. Using total internal 
reflection fluorescence (TIRF) microscopy and a microfluidic flow cell, the hemifusion of single virions 
is visualized. Hemifusion efficiency and kinetics are studied while altering target bilayer cholesterol 
content and sialic-acid donor. Cholesterol ratios tested were 0%, 10%, 20%, and 40%. Sialic-acid 
donors GD1a and GYPA were used. Both cholesterol ratio and sialic-acid donors proved to have a 
significant effect on hemifusion efficiency. Furthermore, comparison between GD1a and GYPA 
conditions shows that the cholesterol dependence of the hemifusion time is severely affected by the 
sialic-acid donor. Only GD1a shows a clear increasing trend in hemifusion efficiency and time with 
increasing cholesterol concentration of the target bilayer with maximum rates for GD1A and 40% 
cholesterol. Overall our results show that sialic acid donor and target bilayer composition should be 
carefully chosen, depending on the desired hemifusion time and efficiency in the experiment.   
  





































































Influenza A is an enveloped, negative-sense single-stranded-RNA virus, member of the 
Orthomyxoviridae family, and a major cause of epidemics in humans [1, 2]. Enveloped viruses have a 
lipid bilayer which has to merge with that of the target cell, a step which is crucial to the viral 
infection pathway [3]. In the influenza infection pathway virions first get internalized by the cell 
through endocytosis. This internalization is highly cell-type dependent: viruses can enter by clathrin-
dependent and clathrin-independent endocytosis, but also by macropinocytosis [4]. After transport 
of the virus through the endosomal network of the host cell, the low-pH environment in the late 
endosome triggers the onset of membrane fusion of the viral and endosomal membranes [5]. 
Following the membrane merging and opening of a pore, the viral genome and its associated 
proteins are released into the cytosol. Release into the cytosol allows the viral ribonucleoprotein 
(vRNP) complexes to travel to the nucleus and use the host cell replication mechanisms to produce 
new viral genome and finally virions [2]. 
 
The viral lipid membrane contains the viral membrane proteins hemagglutinin (HA) and 
neuraminidase (NA). Currently, 16 different subtypes of HA and 9 different subtypes of NA have been 
classified, of which the strains containing subtypes H1N1, H3N2 and H2N2 have been reported to 
circulate amongst the human population [2, 6, 7]. NA is important for the budding of new virus 
particles, whereas the homotrimeric HA protein plays a crucial role in entry into the host cell, being 
responsible for both attachment and catalysis of membrane fusion, a process that is 
thermodynamically favorable but has appreciable kinetic barriers [8]. Antigenic shift and antigenic 
drift are the major causes of yearly influenza epidemics and is therefore studied intensively [9]. HA is 
proteolytically cleaved from the inactive precursor HA0 into the disulfide-linked subdomains HA1 and 
HA2 by host cell enzymes [2, 6, 10, 11]. HA1 forms a globular, receptor-binding domain binding to α-
sialic-acid linkages present on the host cell membrane [9]. In general, these sialic-acids are a part of a 
sugar chain on a glycosylated protein or lipid in the host cell membrane. In the prefusion state, HA1 
envelopes HA2 and thereby may sterically restrict HA2 rearrangements [9]. The low-pH environment 
in the late endosome triggers a conformational change in HA. Upon lowering of the pH, HA1 
dissociates and HA2 unfolds [12]. Due to the extended intermediate, the fusion peptide can insert 
into the target membrane. HA then zippers up onto itself which brings the membranes together. The 
zippering of the HA then forces the membranes to fuse and that leads to the formation of a 
hemifusion stalk where only the proximal leaflets of both membranes have merged. The stalk can 
proceed to a fusion pore, or form an elongated hemifusion diaphragm that may then lead to a pore 
[6, 13]. 
Fusion kinetics, however, do not depend only on HA. It is also greatly affected by the lipid 
composition of both the viral particle and the target membrane [14-16]. In this study we investigate 
the effect of both the sialic-acid donor and the lipid-to-cholesterol ratio of the target membrane on 
the efficiency and kinetics of influenza fusion using a single-particle in vitro assay. The effect of 
cholesterol on influenza fusion has been studied before using bulk liposomal fusion studies, but the 
effects at the single-particle level have not yet been elucidated [15, 17]. Furthermore, there have not 
yet been systematic studies into the effect of the sialic-acid donors. Here we show that both 
cholesterol percentage and sialic-acid donors have a significant impact on the efficiency as well as 
the kinetics of influenza hemifusion. 
  



































































Materials and methods 
Viral particle preparation 
The PR8 and X-31 strains of Influenza A were purchased from Charles River Labs. Viral particles were 
diluted in a PBS (pellets, Sigma-Aldrich) + 0.2 mM EDTA (Promega) solution (pH ~7.4) to a 
concentration of 0.25 mg/ml viral protein. Subsequently the viral particles were labeled using 
Octadecyl Rhodamine B Chloride (R18; Fisher Scientific) dissolved in DMSO by incubating it with the 
viral particle suspension at a final concentration of 3 µM. Incubation was performed for 3 hours at 
room temperature. In order to remove any unincorporated dye a gel filtration column was used (PD-
10 desalting column; GE healthcare). The concentration of the fractions was estimated by observing 
the fractions under the microscope. The fractions with the highest concentrations of viral particles 
were combined and used for the experiment. 
(Proteo-)liposome preparation 
Glycophorin A (GYPA) proteoliposomes were prepared using a mixture of 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), Cholesterol, and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-
(biotinyl) (biotin-PE). The used molar ratio was 60/80/90/100 : 40/20/10/0 : 2.5∙10-3 of DOPC : 
Cholesterol : Biotin-PE with the DOPC : Cholesterol ratios depending on the desired cholesterol 
content of the target membrane. All lipids were dissolved in chloroform and purchased from Avanti 
Polar Lipids. Liposomes were made in a solution of PBS+0.2 mM EDTA to a final concentration of 7 
mM. Liposome formation was done through a freeze-thaw extrusion procedure using a 200 nm 
diameter pore filter (Avanti). Extrusion was performed at 40°C. GYPA insertion was performed using 
detergent. Detergent was added to the liposome suspension followed by GYPA (Sigma-Aldrich) in a 
molar ratio of 2.5∙10-3 after which the detergent was removed using Biobeads (Bio-rad). 
Ganglioside GD1a (GD1a) liposomes were prepared using the same protocol with a few exceptions. No 
insertion was necessary as GD1a could be added together with the other lipids. The used molar ratio 
was 60/80/90/100 : 40/20/10/0 : 2.5∙10-3 : 1 of DOPC : Cholesterol : Biotin-PE : GD1a (Sigma-Aldrich). 
The extrusion filter used had a pore diameter of 100 nm.  
Fusion assay 
Glass coverslips were cleaned using 30 min of sonication in acetone and ethanol followed by 10 min 
sonication in 1M KOH. In between sonication the coverslips were rinsed with deionized water. 
Coverslips were dried overnight at 110°C. Before use, coverslips were cleaned in an oxygen plasma 
cleaner for 30 min and attached to the flow cells. 
Polydimethylsiloxane (PDMS) flow cells were made by pouring PDMS over a mold and curing it to 
harden it. The flow cell consists of 5 separate channels with a width and height of 0.5 x 0.2 mm. The 
setup was placed on a home-built total internal reflection fluorescence (TIRF) microscope, using an 
inverted microscope (IX-71; Olympus) and a high numerical aperture, oil-immersion objective (NA 
1.45, ×60; Olympus). Lipid bilayers were formed by filling the microfluidic channels with the (proteo-) 
liposome suspension and incubating for 45 min. After rinsing with PBS+0.2 mM EDTA labeled viral 
particles were docked to the bilayer. Fluorescein- labelled streptavidin (Life Technologies) was bound 
to the biotin-PE as a pH sensor. The system was acidified to a pH of 5.0 by using citric acid buffer. The 
fluorophores were excited using 488 and 561 nm lasers (Coherent). Viral membrane fluorescence 
(red) and fluorescein pH drop fluorescence (green) were projected on different halves of an EM-CCD 
camera (Hamamatsu). Videos of 1200 frames of 200 ms each were taken for a total movie length of 4 
min. 





































































In order to confirm the fluidity off the lipid bilayers Fluorescence Recovery After Photobleaching 
(FRAP) experiments were performed. In order to do this liposomes were made which included 1 µM 
R18 in ethanol during lipid mixing. These were used to form a lipid bilayer in the same way as during 
a fusion assay. An aperture and high laser power was used to bleach an area of the lipid bilayer after 
which recovery was assessed.  
Analysis 
Home-written Matlab scripts were used to analyze the fusion process. The fluorescein fluorescence 
emission was fitted with the following function:  








In which h is the height of the intensity drop, w is the width of the transition, tc is the time at which 
the transition is half complete, and yoffset is the residual intensity after dissipation. The time of pH 
drop (t0) was defined as (tc + w/2), when fluorescein fluorescence is at ~8%. 
themifusion was determined by using matlab to generate fluorescence over time graphs for every 
individual particle and then manually designating the onset of the peak in each graph. 
The statistical significance of the hemifusion efficiency was tested by comparing the mean using a 
Tukey test (SI table 1). The statistical significance of the hemifusion time was tested by comparing 
the medians using a Wilcoxon rank sum test (SI table 2). 
Results 
Hemifusion was studied using two commonly used influenza A virus  strains: PR8 (H1N1) and X-31 
(H3N2). Single influenza virus particles were immobilized on a supported planar lipid bilayer using 
either GYPA or GD1a as sialic-acid receptor and were fluorescently labeled in the membrane with a 
lipophilic dye, R18 (fig. 1A). The target bilayers contained 0, 10, 20, or 40 percent mol/mol 
cholesterol and imaging was performed using TIRF microscopy (fig. 1B). The fluidity of the bilayer was 
confirmed using FRAP in a separate experiment (SI fig. 1). The experiment starts with flowing in the 
virus particles which dock onto the sialic-acid donors. As the pH is still too high (pH ~7.4), no fusion 
can occur. Only after flowing in citric acid buffer (pH 5.0), the pH is lowered and hemifusion can start 
to occur. The pH drop, after flowing in the citric acid buffer, is monitored by labeling the target 
membrane with fluorescein. When the pH is lowered, the pH-sensitive fluorescence of fluorescein 
drops, indicating the time of the hemifusion trigger (t0). Hemifusion itself is visualized by the diffusion 
of the R18 membrane label from the virus into the target membrane. R18 can start to diffuse after 
the fusion of the proximal leaflets. As R18 is a self-quenching dye this diffusion is characterized by an 
initial spike in fluorescence followed by a gradual decrease in the region of interest. The onset of this 
‘spike’ is defined as the hemifusion time (themifusion) (fig. 1C). 
Hemifusion efficiency is defined as the fraction of particles that undergo hemifusion within the field 
of view and during the time of the experiment (5 minutes). In all conditions hemifusion efficiency 
was affected by the cholesterol percentage of the target bilayers. All conditions show an upward 
trend in hemifusion efficiency as the percentage of cholesterol in the target bilayer increased (fig. 
2A). This upward trend is best illustrated by the results of the X-31 GD1a condition where all of the 




































































tested cholesterol conditions showed a significant change in efficiency (SI table 1). This change in 
efficiency, however, seems to be less pronounced in the conditions which use GYPA as a sialic-acid 
donor. For both X-31 and PR8 the 0% and 10% cholesterol conditions do not show a significant 
difference. Also of note, the hemifusion efficiency of the GD1a condition is significantly higher overall 
than in the GYPA conditions. The higher efficiency of GD1a suggests that the sialic-acid donor also 
has an impact on the hemifusion efficiency. It also shows that the sialic-acid donor has an effect on 
the cholesterol dependency of hemifusion efficiency. As a control, experiments were performed with 
Influenza X-31 and lowered concentrations of GD1a. Trials were performed with 50x less and 400x 
less GD1a in target bilayers with a 40% cholesterol content. 40% was chosen as this was the 
condition closest to natural endosomes [18, 19]. The rationale behind using conditions with 50x less 
and 400x less GD1a is that these concentrations result in the target bilayer having the same 
concentration of sialic-acid or sialic-acid donors respectively as the GYPA condition. As GD1a is used 
in a 400x times higher concentration and GYPA has 8x as many sialic-acids as GD1a (GYPA has 16, 
GD1a has 2) [20, 21]. Both 50x less and 400x less showed hemifusion efficiency comparable to the 
GYPA condition (SI fig. 2). 
While there was an observable trend in all conditions when looking at hemifusion efficiency, this 
does not seem to be the case for hemifusion time, the time between t0 and themifusion. Both of the 
GYPA conditions do not show a trend when comparing the mean hemifusion times to the percentage 
of cholesterol in the target bilayer (fig. 2B). The condition with GD1a however shows a very clear 
trend. The cumulative fusion efficiency plots of the data shows that the time of hemifusion becomes 
higher as cholesterol content of the lipid bilayer increases (fig. 3, SI fig. 3&4). This difference between 
GD1a and GYPA conditions, again, implies that the sialic-acid donor has an effect on the cholesterol 
dependence of hemifusion. The control with lowered GD1a did not show a conclusive effect of sialic-




The increase in hemifusion efficiency at higher cholesterol levels has already been documented in 
the bulk studies by Domanska et al. [17] As they postulate, it is very likely that the effect of 
cholesterol on the intrinsic curvature of the membrane plays a role, as fusion proceeds via strongly 
curved intermediate states [22]. Cholesterol would aid the fusion process as its negative curvature 
would lower the energy necessary to form the intermediate state [23, 24]. While it is very likely that 
the negative curvature of cholesterol plays a large role in the increase of hemifusion efficiency it is 
also likely it is not the only effect of cholesterol. In this study we could see that the cholesterol 
dependency of hemifusion efficiency was modulated by the sialic-acid donors, with the GYPA 
conditions showing a significantly lower response to changes in the composition of the target 
membrane compared to the GD1a condition especially at low cholesterol contents. One explanation 
for this sialic-acid dependency is that cholesterol may interact with the sialic-acid donors, possibly 
forming lipid rafts in one or both of the conditions [25-27]. This recruitment may form a high 
cholesterol area which is either enriched or depleted of sialic-acids which, in turn, could increase or 
decrease the probability of the influenza viral particle docking on to the membrane. For instance, the 
lower cholesterol dependency on hemifusion efficiency of the GYPA condition could mean that GYPA 
recruits cholesterol in lipid rafts and thus reduces the relative difference of cholesterol content in 
specific sialic-acid rich areas between the trials with differing overall cholesterol contents. 
The effect of the sialic-acid donor on the hemifusion efficiency is not well documented nor well 
standardized for experiments. Studies into the fusion of influenza vary in the use of sialic-acid donors 




































































[6, 14, 17, 28]. Yet we find a remarkable effect on both hemifusion efficiency and time when 
comparing the GYPA and GD1a conditions. Possibly the increased efficiency in hemifusion in the 
GD1a condition was based on the difference in sialic-acid concentration. When forming our bilayers 
GYPA and GD1a were added in concentrations following the protocols of Otterstrom et al. and Floyd 
et al., respectively [6, 28]. However, these studies do not use equivalent concentrations of sialic-acid 
with Floyd using 50× more sialic-acid in the bilayer. We tested the different sialic-acid concentrations 
in the 40% cholesterol condition. The low GD1a conditions showed hemifusion efficiency that 
reached similar levels as in the GYPA condition (SI fig. 2). This effect of low GD1a concentration 
would mean that sialic-acid concentration is an important parameter in hemifusion efficiency. 
However, it is also likely that the type of donor plays a role as well. For example, one GYPA 
glycoprotein has on average 16 sialic-acids while one GD1a molecule merely contains two [20, 21]. 
This difference in sialic-acids per molecule could mean that effectively the sialic-acid concentration of 
GYPA could be higher due to a higher local concentration which could have an impact on HA binding.  
The effect of the sialic-acid donor is further seen when studying its effect on hemifusion time. As 
neither the X-31 GYPA nor the PR8 GYPA conditions show any sort of cholesterol dependent trend in 
their hemifusion times while the GD1a condition does. Yet, in the model proposed by Ivanovic et al. 
the hemifusion efficiency and time are correlated to one another [1, 8]. It is possible that the 
increased cholesterol content stabilizes the hemifusion intermediate or that it increases HA insertion 
probability. Both of which could result in the process going much faster [23, 24]. 
The fact that in the GYPA conditions the hemifusion time does not show a cholesterol dependent 
trend is therefore very much of interest. Our GYPA data does not show any correlation between 
hemifusion efficiency and hemifusion time. Therefore, it is likely that there is a factor which does 
affect hemifusion efficiency but not the hemifusion time and that this factor is a property of the 
target bilayer, a factor which still seems to be missing from the current models. A proposition made 
more likely when looking at the low GD1a results as once again the hemifusion efficiency and the 
time do not seem to be correlated. In the case of the comparable concentrations of sialic-acid (50x 
less) we notice a marked drop in hemifusion efficiency, yet the hemifusion time is actually higher 
than in the regular concentration (SI fig. 5). The hemifusion time with the 400x less GD1a condition is 
increased yet in this condition particle docking within field of view was an order of magnitude lower 
than other conditions. As such, the significance of this result is debatable. 
It is possible that an all-or-nothing effect may be at play here. The observed results could be 
explained by GYPA recruiting cholesterol into cholesterol and sialic-acid enriched areas which greatly 
increase the probability of HA2 insertion into the target membrane. These enriched areas would 
make for very hemifusion efficient ‘hotspots’. These hotspots would explain the lack of cholesterol 
dependence in GYPA hemifusion rates. If hotspots have similar local concentrations of cholesterol 
across the conditions it would remove cholesterol as a factor when studying hemifusion time. It 
would also explain why hemifusion efficiency would still be cholesterol dependent as opposed to the 
time. As the overall cholesterol content of the bilayer increased the surface area covered by these 
hotspots would as well. The increased hotspot surface area, in turn, would increase the probability of 
virions docking on or near these hotspots. As the vast majority of hemifusion events would be on or 
near these hotspots this would increase hemifusion efficiency overall. 
Conclusion 
This study shows that both the sialic-acid donor and the cholesterol ratio of the target bilayer has a 
significant effect on the hemifusion efficiency of Influenza viral particles. However, unlike current 
models this effect on hemifusion efficiency does not necessarily correlate to hemifusion time. This 



































































lack of correlation shows that there still is a parameter that the current models do not account for, a 
parameter involving the composition of the target membrane. Our study also reveals that for a 
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Figure 1: Experimental setup. A) Schematic representation of viral particle and lipid bilayer. A planar 
lipid bilayer is formed over a glass surface as a target bilayer. Labeled viral particles are docked and 
the target bilayer is labeled with a pH sensor. The membrane dye (R18) is indicated as red, the pH 
sensor (fluorescein) is indicated as green. As pH drops Fluorescein quenches and upon hemifusion 
the membrane dye diffuses across the planar bilayer. B) A schematic representation of the 
microscope setup. Experiments were performed in separate channels of the microfluidic flow cell. 
Emitted fluorescence is split using a dichroic mirror and imaged on different halves of an EM-CCD 
camera. C) Field of view and resulting graphs. (Top left). Microscope image 5 s before pH trigger. 
Green channel shows fluorescein, red channel shows the viral particles. (Top right). Microscope 
image 240 s after pH drop. Fluorescein signal has lowered and particles have undergone hemifusion. 
(Bottom). The resulting graph after analysis. The drop in fluorescence in the green channel is 
designated t0. A spike in fluorescence in the red channel indicates the themifusion of the particle. 
 
Figure 2: Hemifusion efficiency and hemifusion time. A) The hemifusion efficiency of the different 
conditions. Dots are individual experiments and represent the fraction of particles that underwent 
hemifusion. Weighted median (line) and weighted mean (circle) are shown. Median and mean 
weighted to the number of particles in a trial. B) The hemifusion times of the different conditions. 
Dots are the median hemifusion time of the individual experiments. The median (line) and mean 
(circle) hemifusion times of the pooled experiments are shown. (Numerical values of mean and 
median hemifusion time in SI table 3) 
 
Figure 3: The cumulative distribution of hemifused particles over time in the X-31 GD1a condition. 
Data points represent individual viral particles. Hemifusion times of viral particles were pooled and 
normalized. The data was fitted with the commonly used gamma distribution fit in order to illustrate 
the changes in hemifusion time [6]. Fit parameters in SI table 4. 
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